Multidisciplinary Team (MDT)

Meet Our Expert Doctors

Our multidisciplinary team of renowned oncology specialists brings decades of combined experience in minimally invasive cancer treatment, delivering personalized care to patients across Southeast Asia.

10,000+

International Patients

40+

Countries Served

40yr+

Years of Expertise

40yr+

Years of Expertise
Book a Free Consultation

12+

Expert Specialists

40 yr+

Years Experience

5000+

Patients Treated

1000+

Minimally Invasive Surgeries
Get Started Today

Ready to Begin Your Treatment Journey?

Our patient coordinators are available 24/7 to review your diagnosis, explain which technologies apply, and arrange a free multidisciplinary case review.
Book a Free Consultation

Prof. Song Shijun

Chief Expert of the Oncology Department
Chief Physician • Professor

Introduction

Prof. Song Shijun is a professor, chief physician, and CPC member with over 40 years of clinical experience in oncology. He specializes in chemotherapy, minimally invasive therapy, biotherapy, and targeted therapy for various solid tumors.

Medical Experience

  • Over 40 years of clinical oncology experience.
  • Chief Expert of the Oncology Department and leader of the Multidisciplinary Team (MDT).
  • Specialized in chemotherapy, minimally invasive therapy, targeted therapy, biotherapy, and integrated cancer treatment.
  • Extensive experience in treating complex and advanced-stage malignant tumors.
  • Pioneer in integrating minimally invasive treatment with immunotherapy and precision medicine.
  • Has successfully treated more than 10,000 cancer patients, with many achieving long-term survival exceeding 10 years.
  • Frequently participates in international oncology conferences and promotes medical collaboration across Southeast Asia.

Research Areas

  • Precision Oncology
  • Minimally Invasive Cancer Therapy
  • Targeted Therapy
  • Biotherapy and Immunotherapy
  • Multidisciplinary Team (MDT) Cancer Management
  • Radiofrequency Ablation (RFA)
  • Palliative Care for Advanced Cancer
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Molecular Biomarkers in Cancer
  • Personalized Cancer Treatment Strategies
Book Consultation

Prof. Dai Wenyan

Director of Oncology Department · Director of Breast Cancer Center
Chief Physician

Introduction

Dr. Ma Xiaoying is a renowned oncologist with over 20 years of clinical experience. Specializing in precision minimally invasive therapy, she has treated more than 5,000 international patients, focusing on improving the quality of life and survival rates for advanced-stage cancer patients.

Medical Experience

  • Over 20 years of clinical work in oncology and cancer research.
  • Expertise in multidisciplinary (MDT) consultation and personalized treatment planning.
  • Completed advanced studies at the National University of Singapore (2015) and Sun Yat-sen University Cancer Center (2017 & 2019).
  • Specialist in minimally invasive techniques including interventional therapy, seed implantation, and cryotherapy.

Research Areas

  • Precision minimally invasive cancer treatment technologies.
  • Combination of targeted therapy, immunotherapy, and chemotherapy for refractory tumors.
  • Endoscopic diagnosis and treatment of malignant tumors.
  • Integrated medical models for advanced-stage cancer management.
Book Consultation

Ma Xiaoying

Director of Oncology Department
Associate Chief Physician

Introduction

Dr. Ma Xiaoying is a renowned oncologist with over 20 years of clinical experience. She specializes in minimally invasive precision treatments, combining targeted therapy and immunotherapy to provide individualized plans for advanced cancer patients, focusing on improving their quality of life.

Medical Experience

  • More than 20 years of extensive clinical work in the field of oncology.
  • Expertise in treating advanced and refractory tumors with rich clinical results.
  • Successfully treated over 5,000 international patients, particularly from Southeast Asia.
  • Proficient in implementing multidisciplinary (MDT) treatment plans and managing cancer complications.

Research Areas

  • Integration of minimally invasive technologies (interventional therapy, cryotherapy, microwave ablation) with molecular targeted therapy.
  • Individualized and comprehensive treatment protocols for solid tumors.
  • Advanced techniques in tumor endoscopy for both diagnosis and treatment.
  • Research on biological immunotherapy and endocrine therapy for late-stage cancers.
Book Consultation

Dr. Wang Baoli

Oncology Specialist
Associate Chief Physician

Introduction

Nearly 20 years of clinical oncology experience in China's top-tier Grade A tertiary hospitals. Expert in minimally invasive interventional therapy, chemotherapy, and combined targeted-immunotherapy, focusing on complex cancers and advocating a Multidisciplinary Team (MDT) treatment approach.

Medical Experience

  • Member, Hepatobiliary and Pancreatic Tumors Professional Committee, Guangzhou Anti-Cancer Association
  • Member, Tumor Immunotherapy Professional Committee, Guangdong Pharmaceutical Association
  • Member, Interventional Medicine Professional Committee, Guangzhou Medical Association
  • Member, Liver Cancer Professional Committee, Tumor Rehabilitation Branch, Chinese Geriatrics Society
  • Member, Thyroid Nodule and Tumor Prevention and Control Professional Committee, China Health Care Association
  • Published 5 papers in core medical journals and 1 SCI-indexed paper
  • Awarded 1 Third Prize for Military Medical Achievements
  • Participated in 1 provincial-level government-funded research project

Research Areas

  • Integrated minimally invasive therapy for tumors
  • Multidisciplinary Team (MDT) precision personalized diagnosis and treatment model
  • Application of combined targeted and immunotherapy strategies in oncology
Book Consultation

Dr. Lin Jing

Deputy Director of the International Oncology Ward
Associate Chief Physician

Introduction

Dr. Lin Jing has practiced clinical oncology for nearly 20 years and is a member of the Chinese Anti-Cancer Association. She specializes in minimally invasive targeted therapy, immunotherapy, chemotherapy, radiotherapy, and endocrine therapy for solid tumors, along with endoscopic procedures for gastrointestinal conditions.

Medical Experience

  • Nearly 20 years of clinical experience in oncology
  • Specializes in comprehensive treatment approaches (chemotherapy, radiotherapy, minimally invasive targeted therapy, immunotherapy, endocrine therapy) for solid tumors
  • Skilled in gastrointestinal examination, endoscopic jejunal nutritional tube implantation, and endoscopic photodynamic therapy
  • Familiar with minimally invasive treatment principles including interventional therapy, argon-helium cryotherapy, and radiofrequency ablation
  • Experienced in preventing tumor complications and managing critical illness cases
  • Education: advanced studies at Sun Yat-sen Medical University (2000–2003) and Sun Yat-sen University Cancer Center; further advanced study at the National University of Singapore (2015)

Research Areas

Tumor (oncology) research, with focus on comprehensive/multidisciplinary treatment approaches for solid tumors

Book Consultation
dr-teng-yi

Teng Yi

Oncology Surgery Specialist
Associate Chief Physician

Introduction

Dr. Teng Yi has worked in oncological surgery for many years, focusing on precise diagnosis and treatment of solid tumors such as thyroid, oral/maxillofacial (including tongue, throat, and head-and-neck skin cancers), parotid gland, breast, lung, and colorectal tumors. He has substantial experience in laparoscopic-assisted radical surgery for thyroid, lung, and colorectal cancers, and is skilled in minimally invasive techniques like ultrasound-guided thyroid microwave ablation, aiming to balance precision, minimal invasiveness, and long-term outcomes.

Medical Experience

  • Extensive experience in laparoscopic-assisted radical surgeries for thyroid, lung, and colorectal cancer
  • Skilled in minimally invasive techniques, including ultrasound-guided thyroid microwave ablation
  • Systematic clinical experience in comprehensive treatment strategies for head & neck and gastrointestinal tumors
  • Proficient in neoadjuvant chemotherapy, targeted therapy, immunotherapy, and postoperative adjuvant therapy
  • Further training at the First Affiliated Hospital of Guangxi Medical University and several public Grade-A Tertiary Hospitals, including Hunan Cancer Hospital
  • Participated in one provincial-level research project; led two municipal-level research projects; published multiple papers in national and provincial journals, including 3 SCI-indexed papers

Research Areas

  • Minimally invasive targeted therapy for solid tumors.
  • Interventional therapy, radiofrequency ablation, and argon-helium cryotherapy.
  • Immunotherapy and endocrine therapy.
  • 125I seed implantation techniques.
  • Endoscopic photodynamic therapy.
Book Consultation
Hu Ying

Hu Ying

Deputy Director of International Oncology Ward
Associate Chief Physician

Introduction

Dr. Hu Ying graduated from Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China, and has over 10 years of clinical experience in oncology. She specializes in radiotherapy, chemotherapy, targeted therapy, bronchoscopy, and minimally invasive treatment (particle implantation, microwave ablation, cryotherapy, tracheoscopy microwave therapy) of solid tumors, particularly cancers of the respiratory and digestive systems.

Medical Experience

  • Nearly 20 years of clinical experience in the field of oncology.
  • Advanced study at the National University of Singapore in 2015.
  • Expertise in gastrointestinal examination and endoscopic jejunal nutritional tube implantation.
  • Specialist in the prevention and management of various tumor complications and critical illnesses.
  • Proficient in coordinating multidisciplinary treatments, including chemotherapy and radiotherapy.

Research Areas

  • Minimally invasive targeted therapy for solid tumors
  • Chemotherapy
  • Focus on tumors of the respiratory system and digestive tract
Book Consultation
Wu Wei

Wu Wei

Deputy Director of International Oncology Ward
Associate Chief Physician

Introduction

Wu Wei has practiced clinical oncology for over 10 years. He graduated with a Bachelor's Degree in Clinical Medicine from Shanxi Medical University and is a member of the China Anti-Cancer Association. He is skilled in diagnosing and treating common tumors and is familiar with several minimally invasive treatment techniques.

Medical Experience

  • Over 10 years of clinical experience in oncology
  • Skilled in diagnosis and treatment planning for endometrial, cervical, ovarian, lung, intestinal, gastric, and prostate cancers
  • Proficient in interventional therapy, cryotherapy, microwave therapy, and particle implantation techniques
  • Experienced in managing common tumor-related complications and oncologic emergencies
  • Skilled in performing standard oncology procedures, including thoracic, abdominal, bone, and clavicular puncture

Research Areas

Participated in one Guangzhou municipal-level research project, reflecting some scientific research capability alongside clinical practice

Book Consultation

He Jianyu

Director of the Minimally Invasive Treatment Center
Chief Physician

Introduction

Professor He Jianyu is a renowned international expert in minimally invasive oncology with over 40 years of dedicated clinical experience. He holds a Ph.D. in Surgery from Shanghai Medical College of Fudan University and completed postdoctoral research at Imperial College London. As Director of the Minimally Invasive Treatment Center at Modern Cancer Hospital Guangzhou, he specializes in providing innovative solutions for advanced and complex cancer cases. His medical philosophy integrates both Eastern and Western medical approaches, emphasizing precision, patient autonomy, and ethical practice. He is proficient in applying chemotherapy, targeted therapy, immunotherapy, and advanced minimally invasive technologies to treat various malignant tumors, particularly excelling in complex late-stage cases deemed "inoperable" by conventional standards.

Medical Experience

  • Over 40 years of clinical oncology practice with thousands of surgical procedures performed
  • Expertise in chemotherapy, targeted therapy, immunotherapy, and monoclonal antibodies therapy
  • Advanced training in Western standardized cancer treatment protocols during postdoctoral research at Imperial College London (early 2000s)
  • Proficient in multiple minimally invasive techniques including:
    • Cryoablation (cryotherapy)
    • Radiofrequency ablation
    • Microwave ablation
    • Particle implantation (125 iodine particles)
    • Nanoknife technology
    • Interventional therapy
  • Specialization in complex and advanced metastatic tumor cases
  • Active promoter of Multidisciplinary Team (MDT) approach in cancer treatment
  • Integration of traditional Chinese medicine with modern oncology approaches

Research Areas

  • Effects of Akt inhibitors (Erufosine) on proliferation inhibition in gastric cancer cells
  • Low-dose cisplatin-induced apoptosis mechanisms in gastric cancer
  • Chemotherapy regimen optimization for advanced non-small cell lung cancer (Docetaxel + Oxaliplatin vs. Cisplatin)
  • DCF regimen (Docetaxel + Cisplatin + 5-Fluorouracil) efficacy in advanced gastric cancer
  • Lymphangiogenic factors and their correlation with colorectal cancer metastasis
  • Clinical characteristics and treatment principles of primitive neuroectodermal tumors of bone
  • Minimally invasive technology applications in complex and advanced tumor cases
Book Consultation

Doctors

Introduction

Medical Experience

Research Areas

Book Consultation